Regulus Therapeutics
RGLS
#8762
Rank
S$0.13 B
Marketcap
$2.09
Share price
10.64%
Change (1 day)
13.83%
Change (1 year)

Regulus Therapeutics (RGLS) - Cash on Hand

Cash on Hand as of June 2024 : S$0.12 Billion

According to Regulus Therapeutics's latest financial reports the company has S$0.12 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Regulus Therapeutics - Cash on Hand chart (from 2011 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31S$52.49 M-35.69%
2021-12-31S$81.63 M98.49%
2020-12-31S$41.12 M-10.6%
2019-12-31S$46 M141.64%
2018-12-31S$19.03 M-76.31%
2017-12-31S$80.34 M-27.06%
2016-12-31S$0.11 B-31.73%
2015-12-31S$0.16 B-23.56%
2014-12-31S$0.21 B46.13%
2013-12-31S$0.14 B20.4%
2012-12-31S$0.11 B142.86%
2011-12-31S$49.39 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$5.75 B 4,450.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$9.75 B 7,611.34%๐Ÿ‡ซ๐Ÿ‡ท France
S$2.27 B 1,698.86%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.47 B 7,391.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$3.72 B 2,843.30%๐Ÿ‡บ๐Ÿ‡ธ USA
S$37.22 M-70.58%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.84 B 8,468.71%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA